goodmans llp, posted august 13, 2020 |
Canada: Court Maintains Health Canada's Decision Extending Data Protection to Combination Drugs
|
|
The Federal Court of Canada's recent decision in Natco Pharma (Canada) Inc. v. Gilead Sciences Canada Inc. et al., 2020 FC 788 explores the reach of Canada's data protection regime.
|
|
|
formosa transnational, posted august 2, 2020 |
Taiwan: Patent Linkage System Finally Comes Into Effect
|
|
Beginning August 20, 2019, new drug marketing approval holders (new drug MA holder) are able to list any patents covering their products and assert those patents against generic drug applicants in patent litigation actions at first instance.
|
|
|
ensafrica, posted july 22, 2020 |
South Africa: Healthcare & Life Sciences Newsletter
|
|
There has been much debate in recent years as to the effectiveness of access and benefit sharing (ABS) provisions relating to indigenous biological and genetic resources (IBGRs) and traditional knowledge (TK) or indigenous knowledge (IK).
|
|
|
cms russia, posted july 12, 2020 |
CMS Successfully Defended GE Healthcare Against the Russian Healthcare Authority
|
|
CMS has successfully represented interests of GE Healthcare in several court proceedings against the Russian healthcare regulatory authority (Roszdravnadzor).
|
|
|
GOWLING WLG, POSTED july 5, 2020 |
Gowling WLG Advises Astrazeneca on Landmark Collaboration
|
|
Gowling WLG's global Life Sciences team has advised long-standing client AstraZeneca on a landmark collaboration agreement for the development and distribution of the University of Oxford's potential COVID-19 vaccine.
|
|
|
shearn delamore & co., posted junE 23, 2020 |
Malaysia: Chambers Global Practice Guide - Life Sciences 2020
|
|
Our IP Partner, Timothy Siaw and our associate, Melvin Au have co-authored the Malaysian chapter of the Chambers Global Practice Guide: Life Sciences 2020.
|
|
|
Missed the Life Sciences webinar at the Spring eConference? Check out the recording below. |
WLG 2020 eConference: Life Sciences Group Webinar
|
|
International Regulatory Initiatives Directed at Improving the Delivery of Healthcare in the Fight Against COVID-19.
|
|
|